News

The Federal Commission for the Protection against Sanitary Risks (COFEPRIS) has approved Dengvaxia, tetravalent dengue vaccine, for the prevention of disease caused by all four dengue virus serotypes

STARTRK-NG (which stands for "Studies of Tumor Alterations Responsive to Targeting Receptor Kinases – Next Generation") is a multicenter, open label, dose-escalation and expansion study designed to determine

The Company plans to use the proceeds from the financing to advance its pipeline of direct tumor targeting and immuno-stimulatory epigenetic inhibitors, which includes its two wholly-owned, clinical-stage

The agreement creates opportunities for scientists at Princeton University and Bristol-Myers Squibb to collaborate on top-flight synthetic chemistry research, leveraging the two sites’ close proximity to foster a

Celldex previously announced the collaboration with Roche to evaluate the novel immunotherapy combination in March 2015. Under the terms of the agreement, Roche will provide atezolizumab, and Celldex

In each of these collaborations, Adimab will use its proprietary yeast-based discovery platform to generate IgGs for development as therapeutic products. MD Anderson and Memorial Sloan Kettering retain

The company has also secured an additional $2 million optional financing commitment in this series. Panacea Pharmaceuticals chairman & CEO/CSO Hossein Ghanbari said: "Our lead drug candidate, our

LAL-D is caused by genetic mutations that lead to a marked decrease or loss in LAL enzyme activity in the lysosomes across several body tissue. Kanuma reduces substrate

Novartis unit Sandoz is seeking approval for all indications included in the label of the reference product. More than 120 million people in the European Union are living